OLUMIANT Trademark

Trademark Overview

On Friday, November 20, 2015, a trademark application was filed for OLUMIANT with the United States Patent and Trademark Office. The USPTO has given the OLUMIANT trademark a serial number of 86827315. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, September 2, 2025. This trademark is owned by Eli Lilly and Company. The OLUMIANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of autoimmune diseases and disorders
olumiant

General Information

Serial Number86827315
Word MarkOLUMIANT
Filing DateFriday, November 20, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, September 2, 2025
Registration Number5745831
Registration DateTuesday, May 7, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 9, 2016

Trademark Statements

Description of MarkThe mark consists of literal element "Olumiant" with three curved lines, bands or streaks intersecting, one curving down and intersecting with two that curve upward positioned over the "t".
Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of autoimmune diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 25, 2015
Primary Code005
First Use Anywhere DateTuesday, December 1, 2015
First Use In Commerce DateTuesday, December 1, 2015

Trademark Owner History

Party NameEli Lilly and Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Tuesday, November 24, 2015NEW APPLICATION ENTERED
Wednesday, November 25, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 26, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, December 28, 2015ASSIGNED TO EXAMINER
Monday, December 28, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 9, 2016PUBLISHED FOR OPPOSITION
Tuesday, February 9, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 5, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 23, 2016SOU TEAS EXTENSION RECEIVED
Friday, September 23, 2016SOU EXTENSION 1 FILED
Saturday, October 15, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, October 15, 2016SOU EXTENSION 1 GRANTED
Tuesday, October 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 31, 2017SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2017SOU EXTENSION 2 FILED
Friday, May 12, 2017SOU EXTENSION 2 GRANTED
Friday, September 15, 2017SOU EXTENSION 3 GRANTED
Saturday, May 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 15, 2017SOU TEAS EXTENSION RECEIVED
Friday, September 15, 2017SOU EXTENSION 3 FILED
Tuesday, September 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 27, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, March 27, 2018SOU EXTENSION 4 FILED
Tuesday, March 27, 2018SOU EXTENSION 4 GRANTED
Thursday, March 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 6, 2018SOU TEAS EXTENSION RECEIVED
Thursday, September 6, 2018SOU EXTENSION 5 FILED
Wednesday, September 12, 2018SOU EXTENSION 5 GRANTED
Thursday, September 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 8, 2019USE AMENDMENT FILED
Tuesday, March 26, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 2, 2019ASSIGNED TO LIE
Wednesday, April 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 3, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, April 4, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 8, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, April 24, 2025TEAS SECTION 8 & 15 RECEIVED
Tuesday, September 2, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 2, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 2, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, May 7, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 7, 2019REGISTERED-PRINCIPAL REGISTER

Related Keywords

olumiant pharmaceutical preparations diseases disorders treatment namely autoimmune